Invokana is a prescription medication manufactured by Janssen Pharmaceuticals, Inc. to control blood sugar levels in patients suffering from Type 2 diabetes. Invokana was approved by the FDA in 2013. It is a new type of treatment that works with the kidneys to remove glucose through the process of urination, thus decreasing overall blood sugar levels. Previous treatments had been aimed at increasing the body’s production of insulin.
Since being marketed to patients and their physicians, new studies indicate that the use of Invokana causes both kidney problems and heart problems. Those injured by the use of this medication have claimed that Janssen was aware of the health risks associated with the use of Invokana and failed to properly warn about those risks.
If you or a loved one has suffered an injury related to the use of Invokana or any other medication, please give us a call for a free case evaluation. We have a long history of helping our clients get the compensation they deserve when they were injured by the use of a drug or medication.
Author: Serena C. Montague
Publication Date: January 24, 2017